Cargando…

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma

The development of high-throughput technologies has yielded a large amount of data from molecular and epigenetic analysis that could be useful for identifying novel biomarkers of cancers. We analyzed Gene Expression Omnibus (GEO) DataSet micro–ribonucleic acid (miRNA) profiling datasets to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Hao, Xu, Mingxing, Xiong, Zhiyong, Hu, Kunpeng, Yang, Jiarui, Cao, Mingbo, Zhong, Zhaozhong, Yao, Zhicheng, Deng, Meihai, Liu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950227/ https://www.ncbi.nlm.nih.gov/pubmed/33617479 http://dx.doi.org/10.18632/aging.202606

Ejemplares similares

The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis
por: Yang, Jiarui, et al.
Publicado: (2021)

BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy
por: Liang, Hao, et al.
Publicado: (2019)

Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma
por: Yao, Zhicheng, et al.
Publicado: (2020)

Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis
por: Liang, Hao, et al.
Publicado: (2018)

Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma
por: Tang, Yongchang, et al.
Publicado: (2022)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma
por: Bai, Xue, et al.
Publicado: (2019)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer
por: Wu, Jing, et al.
Publicado: (2020)

MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
por: Wani, Javaid Ahmad, et al.
Publicado: (2022)

Diagnostic and prognostic potential clustered miRNAs in bladder cancer
por: Ware, Akshay Pramod, et al.
Publicado: (2022)

Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
por: Xu, Jianliang, et al.
Publicado: (2019)

The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2022)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

miRNA and Other Non-Coding RNAs as Promising Diagnostic Markers
por: Trzybulska, Dorota, et al.
Publicado: (2018)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma
por: Dong, Junbo, et al.
Publicado: (2016)

Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer
por: da Silva Oliveira, Kelly Cristina, et al.
Publicado: (2016)

High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer
por: Yi, Minhan, et al.
Publicado: (2021)

Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis
por: Yuan, Feng, et al.
Publicado: (2022)

Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer
por: Shi, Can, et al.
Publicado: (2019)

Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
por: Takada, Yukichi, et al.
Publicado: (2021)

Role of Nano-miRNAs in Diagnostics and Therapeutics
por: Coradduzza, Donatella, et al.
Publicado: (2022)

Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia
por: Kawai, Satoshi, et al.
Publicado: (2018)

Identification of Critical miRNAs as Novel Diagnostic Markers for Laryngeal Squamous Cell Carcinoma
por: Luo, Kuo, et al.
Publicado: (2022)

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021)

The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review
por: Mytareli, Chrysoula, et al.
Publicado: (2021)

Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis
por: Wu, Bin, et al.
Publicado: (2022)

Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities
por: Felekkis, Kyriacos, et al.
Publicado: (2023)

The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis
por: Zhang, Xiaoyi, et al.
Publicado: (2018)

The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics
por: Krishnan, Preethi, et al.
Publicado: (2018)

Circulating miRNAs as Potential Marker for Pulmonary Hypertension
por: Wei, Chuanyu, et al.
Publicado: (2013)

miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA
por: Zhang, Jun, et al.
Publicado: (2017)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19
por: Bautista-Becerril, Brandon, et al.
Publicado: (2021)

Independent prognostic miRNAs for bladder urothelial carcinoma
por: Hu, Yingbo, et al.
Publicado: (2017)

miRNAs as prognostic predictors in acute myeloid leukemia
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b6mr7c0kp5p8sismnpmncvsnvq